Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

British Journal of Surgery

Volumn 88, Issue 12, 2001, Pages 1628-1636

  George, M L ^a,d   Dzik Jurasz, A S K ^a   Padhani, A R ^b   Brown, G ^b   Tait, D M ^c   Eccles, S A ^d   Swift, R I ^d  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CHEMOTHERAPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; ENDOTHELIAL GROWTH FACTORS; FOLLOW-UP STUDIES; HUMANS; LYMPHOKINES; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035205433     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1323.2001.01947.x     Document Type: Article

References (38)

1. What is the evidence that tumors are angiogenesis dependent?
2. In vivo monitoring of tumor angiogenesis with MR imaging
3. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma
4. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: Clinical evidence of platelet scavenging?
5. A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
6. VEGF-A, C and D in colorectal cancer progression
7. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics
8. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
9. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols
10. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
11. Prognostic relevance of microvessel density in colorectal tumours
12. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence
13. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma
14. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
15. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients
16. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients
17. Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver mestastasis vascularity and volume
18. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
19. Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients
20. High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer
21. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
22. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
23. Pathophysiologic basis of contrast enhancement in breast tumors
24. Evaluation of angiogenesis and perfusion of bone marrow lesions: Role of semiquantitative and quantitative dynamic MRI
25. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy
26. Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer
27. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum
28. Immunohistochemical expression of vascular endothelial growth factor can predict response to 5-fluorouracil and cisplatin in patients with gastric adenocarcinoma
29. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy
30. Angiogenic activity of cervical carcinoma: Assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome
31. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: Preliminary results and implications for therapy
32. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix
33. Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy
34. Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma
35. Apoptosis and tumor angiogenesis in cervical cancer after preoperative chemotherapy
36. Effects of radiotherapy and estramustine on the micro-vasculature in malignant glioma
37. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
38. Combined effects of angiostatin and ionizing radiation in antitumour therapy